(0.19%) 5 141.50 points
(0.12%) 38 488 points
(0.31%) 17 901 points
(-0.11%) $83.76
(1.20%) $1.946
(0.24%) $2 352.80
(0.50%) $27.67
(1.85%) $939.15
(-0.17%) $0.933
(-0.27%) $10.99
(-0.27%) $0.798
(1.24%) $93.01
40.94% HKD 1.790
Live Chart Being Loaded With Signals
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally...
Stats | |
---|---|
Tagesvolumen | 13.96M |
Durchschnittsvolumen | 476 561 |
Marktkapitalisierung | 750.60M |
EPS | HKD0 ( 2023-08-24 ) |
Last Dividend | HKD1.497 ( 2021-09-13 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 13.77 |
ATR14 | HKD0.0150 (0.84%) |
Volumen Korrelation
Lansen Pharmaceutical Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Lansen Pharmaceutical Korrelation - Währung/Rohstoff
Lansen Pharmaceutical Finanzdaten
Annual | 2022 |
Umsatz: | HKD65.56M |
Bruttogewinn: | HKD44.30M (67.57 %) |
EPS: | HKD0.0205 |
FY | 2022 |
Umsatz: | HKD65.56M |
Bruttogewinn: | HKD44.30M (67.57 %) |
EPS: | HKD0.0205 |
FY | 2021 |
Umsatz: | HKD54.18M |
Bruttogewinn: | HKD34.41M (63.51 %) |
EPS: | HKD0.00224 |
FY | 2020 |
Umsatz: | HKD54.39M |
Bruttogewinn: | HKD35.18M (64.68 %) |
EPS: | HKD0.218 |
Financial Reports:
No articles found.
Lansen Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.0136 | 2011-04-20 |
Last Dividend | HKD1.497 | 2021-09-13 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | HKD2.55 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.25 | -- |
Div. Sustainability Score | 8.21 | |
Div.Growth Potential Score | 2.16 | |
Div. Directional Score | 5.19 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
1513.HK | Ex Dividend Knight | 2023-07-04 | Annually | 0 | 0.00% | |
0560.HK | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
8223.HK | Ex Dividend Junior | 2023-06-08 | Annually | 0 | 0.00% | |
2016.HK | Ex Dividend Junior | 2023-05-17 | Annually | 0 | 0.00% | |
1088.HK | Ex Dividend Knight | 2023-06-21 | Annually | 0 | 0.00% | |
0163.HK | Ex Dividend Junior | 2023-09-26 | Semi-Annually | 0 | 0.00% | |
3709.HK | Ex Dividend Knight | 2023-06-14 | Annually | 0 | 0.00% | |
1665.HK | Ex Dividend Junior | 2023-06-05 | Annually | 0 | 0.00% | |
0700.HK | Ex Dividend Knight | 2023-05-19 | Annually | 0 | 0.00% | |
2218.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.114 | 1.500 | 7.72 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0424 | 1.200 | 8.59 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0604 | 1.500 | -0.440 | -0.661 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.54 | 0.800 | 2.28 | 1.820 | [1 - 3] |
quickRatioTTM | 1.500 | 0.800 | 5.88 | 4.71 | [0.8 - 2.5] |
cashRatioTTM | 0.939 | 1.500 | 5.89 | 8.84 | [0.2 - 2] |
debtRatioTTM | 0.101 | -1.500 | 8.31 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00596 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00460 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.144 | -1.500 | 9.43 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.660 | 1.000 | 2.33 | 2.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.191 | 1.000 | 8.18 | 8.18 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.142 | 1.000 | -0.323 | -0.323 | [0.2 - 2] |
assetTurnoverTTM | 0.371 | 0.800 | -0.859 | -0.687 | [0.5 - 2] |
Total Score | 8.21 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.03 | 1.000 | 8.78 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0604 | 2.50 | -0.283 | -0.661 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00460 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00596 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00938 | 1.500 | -3.27 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0388 | 1.000 | -1.530 | 0 | [0.1 - 0.5] |
Total Score | 2.16 |
Lansen Pharmaceutical
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.